PROFEMUR(R) E CEMENTLESS HIP STEM

{0}------------------------------------------------ K111698(pg 1/2) Image /page/0/Picture/1 description: The image shows the logo for Wright Medical Technology. The logo consists of a stylized "W" made up of three black bars, followed by the words "WRIGHT MEDICAL TECHNOLOGY" stacked on top of each other. Below the logo is the text "A Wright Medical Group Company." AUG 1 9 2511 A Wright Medical Group Company # 510(k) Summary of Safety and Effectiveness In accordance with the Food and Drug Administration Rule to implement provisions of the Safe Medical Devices Act of 1990 and in conformance with 21 CFR 807.92, this information serves as a Summary of Safety and Effectiveness for the use of the PROFEMUR® E Cementless Hip Stem. (a)(1) Submitted By Submitter's Name: Date: Contact Person: (a)(2) Device Name Proprietary Name: Common Name: Classification Name and Reference: Subject Device Product Code and Panel Code: (a)(3) Predicate Device Predicate Proprietary Name: Predicate Classification and Number: Wright Medical Technology, Inc. 5677 Airline Rd. Arlington, TN 38002 800-238-7188 (phone), 901-867-4190 (fax) August 19, 2011 Gregory Neal Regulatory Affairs Specialist II PROFEMUR® E Cementless Hip Stem Hip Stem 21 CFR 888.3320 Hip joint metal/metal semiconstrained. with an uncemented acetabular component, prosthesis Class III Orthopedics/87/ JDL. KWA, I.PH, LZO STEM Hip Replacement System 888.3358 LPH Hip joint metal/polymer/ metal semiconstrained porous-coated uncemented prosthesis Class II (510k-K021346) PRO-FEMUR Hip System 888.3353 LZO Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Class II (510k-K012091) Metal TRANSCEND Articulation System 888.3320 JDL Hip joint metal/metal semiconstrained, with a cemented acetabular component prosthesis Class III 888.3330 KWA Hip joint metal/metal semiconstrained, an uncemented acetabular with component prosthesis Class III (510k-K004043) ## (a)(4) Device Description The modular PROFEMUR® E Cementles Hip Stems hip stem is an uncemented distal femoral implant designed to couple with Wright Medical Technology's PROFEMUR® CoCr modular necks. The stem design was developed , from the previously marketed PROFEMUR® Z Hip Stem (STEM) K021346) and possesses the identical modular neck taper socket and is made of the identical Titanium alloy (ASTM F620) as previous hip stem designs by Wright, {1}------------------------------------------------ ## (a)(5) Intended Use of the Device Intended Use The PROFEMUR® E Cementless Hip Stem is intended for use in total hip arthroplasty for reduction or relief of pain and/or improved hip function in skeletally mature patients. ## Indications for Use - non-inflammatory degeneralive joint disease such as osteoarthritis. avascular necrosis, ankylosis, protrusio 1. acetabuli, and painful hip dysplasia; - inflammatory degenerative joint disease such as rheumatoid arthritis; 2. - 3. correction of functional deformity: and, - revision procedures where other treatments or devices have failed 4. The PROFEMUR® E Cementless Hip Stem is a single use component, intended for use in conjunction with associated ceramic or metal femoral heads as part of an uncemented total hip arthroplasty. # (a)(6) Technological Characteristics of the Device The indications for use for the PROFEMUR® E Cementless Hip Stem are identical to those for all existing Wright PROFEMUR® hip stems. The indications are applied to all PROFEMUR® hip stems and have been cleared in 510/k)s: K041114, K041586, K051995, K052915, K053588, K060663, K081090, K091423, and K 100866. The PROFEMUR® E Cementless Hip Stem is made of the same Titanium alloy and features a corundum blast surface finish similar to the PROFEMUR® Z Hip Stem (K021346). The PROFEMUR® E Cementless Hip Stem shares the rectangular cross-section of the predicate devices, and is designed to feature additional tapered lateral fins on cach stem side. # (b)(1) Nonclinical Testing The PROFEMUR® E Cementless Hip Stem represents a minor change to the PROFEMUR® Z Hip Stem (K021346). Proximal and distal fatigue. fretting, and distraction evaluations were conducted on the PROFEMUR® E Cementless Hip Stem. The results were similar to the PROFEMUR® Z Hip Stem (K021346). ## (b)(2) Clinical Testing Clinical data was not provided for the class III modular hip stem. ## (b)(3) Conclusions The indications for use of the PROFEMUR® E Cementless Hip Stem are identical to the previously cleared predicate devices. The design features and materials of the subject devices are substantially equivalent to those of the predicate devices. The fundamental scientific technology of the subject device has not changed relative to the predicate devices. The safety and effectiveness of the PROFEMUR® E Cementless Hip Stem is adequately supported by the substantial equivalence information, and analysis data provided within this Premarket Notification. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or a stylized human figure with outstretched arms. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Wright Medical Technology, Inc. % Mr. Gregory Neal Regulatory Affairs Specialist II 5677 Airline Road Arlington, Tennessee 38002 AUG 19 2011 Re: K111698 Trade/Device Name: PROFEMUR® E Cementless Hip Stem Regulation Number: 21 CFR 888.3330 Regulation Name: Hip joint metal/metal semi-constrained, with an uncemented acetabular component, prosthesis Regulatory Class: Class III Product Code: KWA, JDL, LPH, LZO Dated: July 21, 2011 Received: July 22, 2011 Dear Mr. Neal: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976. the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must {3}------------------------------------------------ Page - 2 - Mr. Gregory Neal comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820): and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.html for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, Mark A. Millman Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # KIII698 (pg 1/1) Image /page/4/Picture/1 description: The image shows the word "WRIGHT." in a bold, sans-serif font. Below the word is a graphic of two stylized, overlapping shapes that resemble wings or chevrons. The overall design is simple and monochromatic, with a focus on the typography and the geometric shapes. # Indications for Use Device Name: PROFEMUR® E Cementless Hip Stem Indications For Use: The PROFEMUR® E Cementless Hip Stem is indicated for use in total hip arthroplasty for reduction or relief of pain and/or improved hip function in skeletally mature patients with the following conditions: - non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, 1. ankylosis, protrusio acetabuli, and painful hip dysplasia; - inflammatory degenerative joint disease such as rheumatoid arthritis; 2. - correction of functional deformity; and, 3. - revision procedures where other treatments or devices have failed 4. The PROFEMUR® E Cementless Hip Stems are single use components, intended for use in conjunction with associated ceramic or metal femoral heads as part of an uncemented total hip arthroplasty. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) for. m melker Page (Division Sign-Off) (Division Sign-Old) Division of Surgical, Orthopedic, Division of Surg and Restorative Devices K111698 510(k) Number Page 1 of 1 1